Dyfira 240mg 60 Capsules

Babies: It is not applicable for babies. Lactating mothers: Information on the use of this medicine during breastfeeding is not available. Seek doctor advice before using this medicine. Pregnancy: It is unsafe to use this medicine during pregnancy.
Human studies have shown that the drug causes harmful effects on the developing baby. Seek the doctor's advice before using this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine. Driving: This medicine causes dizziness, sleepiness and affects your ability to drive.
Do not drive if you experience these symptoms while taking this medicine. Kidney: This medicine should be, used with caution in patients with severe kidney disease.
Dose adjustment is required. Seek a doctor's advice before taking this medicine. Liver: This medicine should be, used with caution in patients with severe liver diseases.
Studies have shown that dose adjustment is not required in these patients. Seek a doctor's advice before using this medicine..

Nausea Diarrhoea Abdominal pain Flushing.

Dyfira belongs to the class immunomodulators used to treat multiple sclerosis. It works by preventing the inflammation and immune response that causes nerve damage in multiple sclerosis..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as prescribed by your doctor. • To get better results to take this medicine at a fixed time. • Finish the course of this medicine. • Avoid excess consumption of alcohol while taking this medicine as it may worsen your side effects. • To avoid stomach upset, take this medicine with food. • If you experience any infection symptoms such as fever, sore throat, and diarrhoea while taking this medicine, inform your doctor..

Major • Dyfira + Adalimumab: Concurrent use of these medicines lead to an increase in the risk of serious life-threatening infections • Dyfira + Baricitinib: Concurrent use of these medicines lead to an increase in the risk of serious life-threatening infections • Dyfira + Certolizumab: Concurrent use of these medicines lead to an increase in the risk of serious life-threatening infections • Dyfira + Etanercept: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections • Dyfira + Leflunomide: Concurrent use of these medicines lead to an increase in the risk of life-threatening infections Moderate • Dyfira + Abatacept: Concurrent use of these medicines lead to an increase in the risk of serious infections • Dyfira + Azathioprine: Concurrent use of these medicines lead to an increase in the risk of serious infections • Dyfira + Bleomycin: Concurrent use of these medicines lead to an increase in the risk of serious infections • Dyfira + Carboplatin: Concurrent use of these medicines lead to an increase in the risk of serius infections • Dyfira + Dexamethasone: Concurrent use of these medicines lead to an increase in the risk of serious infections.